Not applicable - Healthy volonteers research hub

A phase 1 study to assess the mass balance, pharmacokinetics, metabolism, and excretion of GSBR-1290, containing a microtracer dose of [14C] GSBR-1290, in healthy participants

This study looks at how a new medicine, GSBR-1290, travels through the body of healthy volunteers. Researchers want to understand how it's absorbed, changed, and leaves the body, using a tiny, safe amount of a special version of the medicine.